The authors additionally evaluated RRM1 expression by immunohistochemistry in a cohort of 97 GBM patients and showed that high levels of RRM1 predicted poor OS of the patients in a Cox regression model adjusted by type of surgery [32]. Here, RRM1 is linked to glioblastoma.